CYP1B1: A Unique Gene with Unique Characteristics

Author(s): Muneeb A. Faiq, Rima Dada, Reetika Sharma, Daman Saluja, Tanuj Dada.

Journal Name: Current Drug Metabolism

Volume 15 , Issue 9 , 2014


Become EABM
Become Reviewer

Abstract:

CYP1B1, a recently described dioxin inducible oxidoreductase, is a member of the cytochrome P450 superfamily involved in the metabolism of estradiol, retinol, benzo[a]pyrene, tamoxifen, melatonin, sterols etc. It plays important roles in numerous physiological processes and is expressed at mRNA level in many tissues and anatomical compartments. CYP1B1 has been implicated in scores of disorders. Analyses of the recent studies suggest that CYP1B1 can serve as a universal/ideal cancer marker and a candidate gene for predictive diagnosis. There is plethora of literature available about certain aspects of CYP1B1 that have not been interpreted, discussed and philosophized upon. The present analysis examines CYP1B1 as a peculiar gene with certain distinctive characteristics like the uniqueness in its chromosomal location, gene structure and organization, involvement in developmentally important disorders, tissue specific, not only expression, but splicing, potential as a universal cancer marker due to its involvement in key aspects of cellular metabolism, use in diagnosis and predictive diagnosis of various diseases and the importance and function of CYP1B1 mRNA in addition to the regular translation. Also CYP1B1 is very difficult to express in heterologous expression systems, thereby, halting its functional studies. Here we review and analyze these exceptional and startling characteristics of CYP1B1 with inputs from our own experiences in order to get a better insight into its molecular biology in health and disease. This may help to further understand the etiopathomechanistic aspects of CYP1B1 mediated diseases paving way for better research strategies and improved clinical management.

Keywords: CYP1B1, cytochrome, drug metabolism, functional genomics, gene expression, glaucoma, ideal cancer marker, pharmacogenomics, predictive diagnosis.

Rights & PermissionsPrintExport Cite as


Article Details

VOLUME: 15
ISSUE: 9
Year: 2014
Page: [893 - 914]
Pages: 22
DOI: 10.2174/1389200216666150206130058
Price: $58

Article Metrics

PDF: 53